AGREEMENT

EXHIBIT A

AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Stock of Mirum Pharmaceuticals, Inc.

Date: September 5, 2023				XXXXXXX LIFE SCIENCES IX, L.P.
				By FHMLS IX, L.P., its general partner
				By FHMLS IX, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLS IX, L.P.
				By FHMLS IX, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLS IX, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				XXXXXXX LIFE SCIENCES X, L.P.
				By FHMLS X, L.P., its general partner
				By FHMLS X, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLS X, L.P.
				By FHMLS X, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer

Date: September 5, 2023				FHMLS X, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P.
				By:		FHMLSP, L.P., its General Partner
				By:		FHMLSP, L.L.C., its General Partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLSP, L.P.
				By:		FHMLSP, L.L.C., its General Partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLSP, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.
				By:		FHMLSP Overage, L.P., its General Partner
				By:		FHMLSP Overage, L.L.C., its General Partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLSP OVERAGE, L.P.
				By FHMLSP Overage, L.L.C., its General Partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer

Page 2

Date: September 5, 2023				FHMLSP OVERAGE, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				XXXXXXX LIFE SCIENCES XI, L.P.
				By FHMLS XI, L.P., its general partner
				By FHMLS XI, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLS XI, L.P.
				By FHMLS XI, L.L.C., its general partner
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				FHMLS XI, L.L.C.
				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, Chief Financial Officer
Date: September 5, 2023				By:		*
						Xxxxx X. Xxxxxx
Date: September 5, 2023				By:		*
						Xxxxxxx X. Xxxxx
Date: September 5, 2023				By:		**
						Xxxxxx Xxx
Date: September 5, 2023				By:		**
						Xxxxx Xxxxx
Date: September 5, 2023				By:		***
						Xxxxxx Xxxxx

Page 3

Date: September 5, 2023				By:		/s/ Xxxxx X. Xxxxxx
						Xxxxx X. Xxxxxx, as Attorney-in-Fact

* This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017.

** This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021.

*** This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022.

Page 4